THE INFLUENCE OF THE SARS-COV-2 VIRUS ON THE EVOLUTION OF TRANSAMINASES

This paper is both a retrospective statistical study and a suggestive case presentation on the evolution of transaminases before and after SARS-COV-2 infection. In this paper, the transaminase results for a group of over 200 patients who had Covid 19 disease were determined and recorded. The results obtained were compared with normal values. For statistical processing of the data, patients with Covid 19 were divided into cohorts selected according to age, sex and environment, rural or urban, and the results obtained were compared with normal range values and analyzed. The study includes a critical look at the evolution of transaminase concentration from infection with the SARS-COV-2 virus to recovery. The determination of transaminases was performed on an automatic device of the BioSystems BA 400 type from serum samples collected from patients positive for SARS-CoV-2 virus infection, using a kinetic method of analysis without pyridoxal phosphate, standardized by the International Federation for Clinical Chemistry (IFCC).